✦ LIBER ✦

P2. Downregulation of urokinase-type plasminogen activator inhibitor (PAI-1) in pancreatic cancer

✍ Scribed by R. Metzger; U. Warnecke-Eberz; K.L. Prenzel; S.E. Baldus; J. Brabender; D. Vallböhmer; A.H. Hölscher; P.M. Schneider

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Plasminogen Activator Inhibitor Type-2 (

✍ Jeannette Reinartz; Birgit Schaefer; Michael J. Bechtel; Michael D. Kramer 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 257 KB

Role of urokinase-type plasminogen activ

✍ E. Steiner; K. Pollow; D. Hasenclever; W. Schormann; M. Hermes; M. Schmidt; A. P 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 799 KB

The plasminogen activator urokinase and

✍ N. Gleeson; R. Gonsalves; J. Bonnar 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 347 KB

The plasminogen activator urokinase and

✍ N. Gleeson; R. Gonsalves; J. Bonnar 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 137 KB

Downregulation of urokinase-type plasmin

✍ Dhungana Sandra; Madhyastha Radha; Madhyastha Harishkumar; Nakajima Yuichi; Omur 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 353 KB

Expression of urokinase-type plasminogen

✍ Li Zhou; Yoshitake Hayashi; Takashi Itoh; Weiping Wang; Jing an Rui; Hiroshi Ito 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 575 KB